SCHEMBL9058089

SCHEMBL9058089

COc1cc2occ(Br)c(=O)c2cc1OC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ACHE P22303 4/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.46
▸ PTPN1 P18031 1/20 0.46
▸ PPARG P37231 1/20 0.46
▸ RAB9A P51151 4/20 0.45
▸ KLK7 P49862 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ MAOA P21397 2/20 0.42
▸ MAOB P27338 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ PTGS2 P35354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28314002 0.84 NPC1 (0.53) NPC1MEN1KMT2AACHEHDAC6
SCHEMBL16445878 0.79 NPC1 (0.49) NPC1MEN1KMT2AACHEHDAC6
SCHEMBL9057896 0.77 ALDH1A1 (0.60) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL5242625 0.77 RAB9A (0.61) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL13978684 0.76 MAOB (0.53) NPC1MEN1KMT2AACHEHDAC6
SCHEMBL1441804 0.73 PDE10A (0.43) NPC1MEN1KMT2AACHEHDAC6
SCHEMBL4844181 0.73 RAB9A (0.76) NPC1ACHEHDAC6PTPN1PPARG
SCHEMBL30573375 0.72 RAB9A (0.81) NPC1MEN1KMT2AACHEHDAC6
SCHEMBL7030328 0.72 RAB9A (0.81) NPC1MEN1KMT2AACHEHDAC6
SCHEMBL29184856 0.72 KCNA3 (0.48) NPC1MEN1KMT2AACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996012718-A1 NOUVELLES 2-[1-(φ-PHENOXYALCOYLPIPERIDIN-4-YL)AMINOMETHYLENE]-2H-BENZOFURAN-3-ONES SUBSTITUEES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE PIERRE FABRE MEDICAMENT (FR) 1996-05-02 — — WO disclosed
Send feedback